Search for: "Abbott Products Inc"
Results 501 - 520
of 664
Sorted by Relevance
|
Sort by Date
15 Jul 2011, 8:59 am
” (Waste Management of Alameda County , Inc. v. [read post]
19 Feb 2010, 2:38 pm
They may however be granted for medicinal products for use in such methods. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive… [read post]
28 May 2010, 11:51 pm
Abbott Labs., 339 F.3d 1324, 1328 (Fed. [read post]
19 Aug 2020, 3:00 am
More recently, at the 2020 Abbott & Kindermann, Inc., annual conference, we noted that Governor Newsom was planning to pause a new state law requiring sola [read post]
10 Apr 2013, 10:47 am
Abbott, Diane Kindermann, Katherine J. [read post]
30 Jun 2011, 5:00 am
Blackpowder Products, Inc., No. 4:06-cv-00169-RAW, slip op. [read post]
15 Dec 2013, 4:00 am
Abbott and Haliburton Company Limited, et al. [read post]
7 Sep 2011, 4:22 am
Highlights this week included: US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al (Inventive Step) (Orange Book Blog) (Patently-O) (Patent Docs) (Patent Docs) (IPBiz) (Patent Law Practice Center) (Patent Baristas) US: FTC issues long-awaited final report on authorized generics; report examines both the short-term effects and long-term impact on competition and drug prices (FDA Law Blog) (Orange Book Blog) Please join the… [read post]
19 Aug 2010, 3:00 am
Abbott Laboratories (E.D. [read post]
10 Jan 2018, 2:17 pm
Animal Science Products, Inc. v. [read post]
6 Jul 2007, 4:29 am
Hoffman-La Roche, Inc., 618 N. [read post]
1 Dec 2007, 9:00 am
: (IAM),Latest WIPO SME newsletter: (WIPO),PharmaRoche extends patent fight (to include Abbott) over diabetes test strips: (IPLaw360),Drug innovation and marketing: (Tech Innovation and IP),WHO funded study reveals 3.1% of drugs sold in India are counterfeit suspects: (SpicyIP), Another piece on the impressive R&D programs of India's (generic?) [read post]
24 Aug 2011, 12:33 am
Novartis (IPBiz) Simcor (Niacin, Simvastatin) – US: Abbott Laboratories files patent infringement complaint against Teva in response to Para IV challenge (Patent Docs) Vanos (Fluocinonide) – US: Medicis and Nycomed settle Vanos patent dispute (Patent Docs) Viagra (Sildenafil) – US: Pfizer’s patent on Viagra upheld by the EDVA: Pfizer v Teva (Rocket Docket IP Blog) (Patent Docs) (The IP Factor) [read post]
9 May 2011, 8:09 am
Optics, Inc., 2011 U.S. [read post]
26 Oct 2022, 9:06 pm
The FDA has been investigating the outbreak since late September and has traced the implicated fish to Mariscos Bahia Inc. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes… [read post]
1 Jul 2009, 7:14 am
(The SPC Blog) EU: Germany refers question to ECJ concerning SPCs for plant protection products (The SPC Blog) EU: Nutritional supplements: is Class 5 their natural home? [read post]
14 May 2021, 6:01 am
Abbott Labs., 297 F.3d 544, 546 (7th Cir. 2002). [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
